December 26, 2025 08:02 ET | Source: Arcadia Biosciences, Inc. DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.®…
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…
London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs…
KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”),…
16 September 2025 – Six recipients have received Tech365 Incubate grants, each worth up to USD 40,000, the International Olympic…
August 16, 2025 04:05 ET | Source: Digitalist Group Oyj REGISTRATION OF THE COMBINATION OF SHARES OF DIGITALIST GROUP PLC,…
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of…
The gateway to professional audio starts at $34.9. SHENZHEN, China, May 27, 2025 /PRNewswire/ -- Hollyland, a leading provider of…